Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001317652 | SCV001508322 | uncertain significance | Hereditary spastic paraplegia 39 | 2020-08-25 | criteria provided, single submitter | clinical testing | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with PNPLA6-related conditions. This variant is present in population databases (rs752720134, ExAC 0.002%). This sequence change affects codon 541 of the PNPLA6 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the PNPLA6 protein. |